For following the competition: what moved in each program, several studies read as one move.
- RBM39 Degrader ST-01156
- xaluritamig
- DXC008
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Sarcoma, Ewing to watchlistEvery Monday by email · turn it off any timePro · free during the beta